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Summary 
Mononuclear phagocytes (monocytes, macrophages, and dendritic cells) play major roles in human 
immunodeficiency virus  (HIV)  persistence  and  disease  pathogenesis.  Macrophage  antigen 
presentation and effector  cell functions are impaired by HIV-1  infection. Abnormalities of 
macrophage effector cell function in bone marrow, lung, and brain likely result as a direct consequence 
of cellular activation and HIV replication. To further elucidate the extent of macrophage dysfunction 
in HIV-1 disease, a critical  activation-specific regulatory molecule, nitric oxide (NO'),  which 
may contribute to diverse pathology, was studied. Little, if any, NO" is produced by uninfected 
human monocytes. In contrast, infection with HIV-1 increases NO" production to modest, but 
significant levels (2-5 #M). Monocyte activation (with lipopolysaccharide,  tumor necrosis factor 
a, or through interactions with astroglial cells) further enhances NO" production in HIV-infected 
cells, whereas its levels are diminished by interleukin 4. These results  suggest a possible  role 
for NO" in HIV-associated pathology where virus-infected macrophages are found. In support 
of this hypothesis, RNA encoding the inducible NO synthase (iNOS) was detected in postmortem 
brain tissue from one pediatric AIDS patient with advanced HIV encephalitis.  Corresponding 
iNOS mR.NA was not detected in brain tissue from five AIDS patients who died with less significant 
brain disease. These results demonstrate that HIV-1 can influence the expression of NOS in both 
cultured human monocytes and brain tissue. This newly described feature of HIV-macrophage 
interactions suggests previously unappreciated mechanisms of tissue pathology that result from 
productive viral replication. 
D 
uring the course of HIV infection, many patients de- 
velop neurocognitive defects, a condition termed the 
HIV-l-associated cognitive/motor complex (1, 2). The AIDS 
dementia complex (ADC), a severe form of this impairment, 
occurs in 20-30% of immunosuppressed  patients with neu- 
rological deficits (1, 2). Although the mechanisms of HIV- 
1-induced central nervous system (CNS) disorders remain un- 
known, they are associated with productive viral replication, 
1 The first  two  authors contributed  equally  to the paper. 
particularly in brain macrophages, multinucleated giant cells, 
and microglia (3, 4).  Our recent work demonstrated that 
interactions between HIV-infected monocytes and astroglial 
cells produce high levels of proinflammatory cytokines (TNF- 
or, IL-13), platelet-activating factor (PAF) (5),  and eicosa- 
noids (6). These potent, cell-derived effector molecules are 
cytotoxic when added to primary neuronal cultures and are 
also detected in the cerebrospinal fluid of HIV-infected sub- 
jects with neurological deficits (7-9). 
The final common pathway for neuronal injury in HIV-1 
disease likely revolves around stimulation of neuronal N-meth- 
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rotoxicity in primary neuronal cultures induced by stimula- 
tion of NMDA receptors  is mediated in part by nitric oxide 
(NO') 2 (14-17).  NO"  is a powerful endogenous mediator 
for numerous physiological responses  that are implicated in 
the antimicrobial, antiviral,  and antiproliferative activities 
(18-20), as well as in many manifestations of tissue and, in 
particular,  of brain injury (19, 21-23). 
Production of NO" is regulated in seemingly  complex ways 
that are host dependent. Treatment of murine macrophages 
with IFN-~ and LPS induces the expression of iNOS, a gene 
encoding an inducible isoform of NOS that produces large 
amounts of NO" from a guanidino nitrogen of r-arginine 
(19, 20).  The induction of iNOS activity in human mono- 
cytes has been variably reproducible (24-29). The underlying 
cause for this species heterogeneity has not been resolved, 
but may underscore important intraceUular  signaling differ- 
ences between mouse and human macrophages, as well as 
variations in cultivation conditions of cells. In this paper we 
demonstrate  induction of iNOS  in  HIV-infected human 
monocytes, a population of ceils that has been used as model 
of tissue macrophage function (30,  31). We also show that 
this NOS induction is subject to both positive and negative 
regulation by the immune system cytokine network. HIV-1 
can both prime monocytes for NO" induction by LPS or TNF- 
cr, as well as induce NO" de novo. Although the levels of 
NO" produced by HIV-infected human monocytes are not 
striking, they are significant across donor and assay systems, 
and may participate in producing the CNS injuries associated 
with HIV-1  infection of brain macrophages. 
Materials and Methods 
Isolation and Prolmgation of  Human Monocytes and Astroglia.  Mono- 
cytes were recovered  from PBMC of  HIV- and hepatitis  B-seronega- 
tive donors after leukapheresis and purified by countercurrent cen- 
trifugal elutriation. Cell suspensions were >98% monocytes  by the 
criteria of cell morphology  on  Wright-stained  cytosmears, by 
granular peroxidase, and by nonspecific  esterase. Monocytes were 
cultured as adherent monolayers (106 cells/ml) in DMEM (Sigma 
Chemical Co., St. Louis, MO) supplemented with 10% pooled 
human sera, 50 #g/ml gentamicin, and 1,000 U/ml highly purified 
(<0.01 ng/ml endotoxin) recombinant human M-CSF (Genetics 
Institute,  Cambridge, MA) for 7 d. 
The U251 MG human astroglial tumor-derived cell line was ob- 
tained from D. Bigner (Duke University, Durham, NC) (32). The 
calls were grown as adherent rnonolayers in DMEM with 10% 
heat-inactivated fetal bovine serum (HyClone Laboratories,  Logan, 
UT) (or human serum in co-culture experiments) and 50/xg/ml 
gentamicin. 
HIV Infection of Monocytes.  Adherent monocytes cultured for 
7 d were exposed to  105 TCIDs0/ml of a monocytotropic viral 
strain, HIV-1ADA. All viral stocks were tested and found free of 
mycoplasma contamination (Gen-probe II; Gen-probe Inc., San 
Diego, CA). Culture medium was half-exchanged  every  2-3 d. Re- 
2 Abbreviations used in this paper: DETC, diethyldithiocarbamate;  EPR, 
electron paramagnetic  resonance;  gp, glycoprotein;  iNOS, inducible  nitric 
oxide synthase; NMA, NC-methyl-r-arginine;  NO', nitric oxide; KT, 
reverse transcriptase. 
verse transcriptase (RT) activity was determined  in replicate  samples 
of culture fluids as described previously (6). 
Coupled RT-PCR analysis of RNA.  RNA was isolated from 
2-5  x  106 cells  by acid guanidinm thiocyanate-phenol-chloroform 
extraction using RNAzol (Biotecx Laboratories, Inc., Houston, 
TX) and reverse transcribed by Moloney murine leukemia vires 
RT using random hexamers as primers (all reagents were included 
in the GeneAmp KNA PCR Kit; Perkin-Elmer Corp., Norwalk, 
CT). Complementary DNA was divided into several  aliquots that 
were amplified with different primer pairs. To increase specificity 
of the analysis,  products of the PCR were visualized in some cases 
by Southern hybridization, using oligonucleotides corresponding 
in sequence to an internal portion of the predicted fragment as the 
probe. PCR primers used for NOS RNA detection were designed 
to allow discrimination between the constitutive (cNOS) and in- 
ducible (iNOS) forms of NOS by exploiting the fact that the cDNA 
for both mouse and human iNOS has a gap of about 130 bp 5' 
to the flavinmononucleotide  (FMN) binding site, compared to the 
constitutive form (33-35). Therefore, amplification  ofiNOS with 
these primers produces a band of  614 bp, whereas constitutive NOS 
RNA would give rise to a product of 748 bp. Only the 614-bp 
product was detected in monocytes  and in the brain samples; there- 
fore it is designated iNOS. Control experiments with primers that 
specifically  amplify  a 3' untranslated  region of  iYOS mKNA (Clon- 
tech, Palo Alto, CA) produced identical results and demonstrated 
the validity of the RT-PCK assay. Sequences of the primers and 
probes used in this study are shown in Table 1. PCK reactions were 
assembled according to the protocol supplied with the kit. Am- 
plification  was performed  either for 28 cycles  (30s, 94~  30 s, 50~ 
I rain, 72~  for HIVpol, fl-actin, and glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) primers; or for 40 cycles (45 s, 94~ 
45 s, 58~  2 rain, 72~  with NOS primers. Amplifications  were 
preceded by denaturation step (3 rain, 94~  and followed by a 
final extension period (5 rain,  72~ 
Analysis of  NO" in Culture Fluids.  NO" production was initially 
assessed by total nitrite formation. Nitrites were measured by the 
Griess reaction (36). 100 #1 of culture medium without phenol 
red was mixed with 100 #1 of Griess reagent (1% sulfanilic acid, 
0.1% D-naphthyl  ethylenediamine  [both from Sigma  Chemical  Co.] 
in 5% phosphoric acid) in a microplate, and results were read after 
a 20-rain incubation at room temperature in an ELISA  reader (Bio- 
Tek Instruments, Burlington, VT) at 570 nm. Standard curves of 
various fixed  concentrations  of  sodium nitrite (Sigma  Chemical  Co.) 
were generated alongside the experimental samples. 
Electron Paramagnetic Resonance Detection of  Free NO" by Spin.Trap 
Methods.  A useful technique for detecting the presence of NO" 
is the use of the Fe-diethyldithiocarbamate  (DETC)2 complex to 
spin-trap NO" in the form of the ternary paramagnetic complex 
NO-Fe-(DETC)v The advantage  of this method is that this NO'- 
specific spin-trap can be detected  in the liquid or solid aqueous  phase 
(37-39). To perform this sensitive spin-trap method, cell cultures 
were prepared as usual  with HIV-infected  or uninfected  macrophages 
(which served as the control). After 5-7 d in culture, DETC (2.5 
mg/ml) was added to the culture fluid, followed by the combina- 
tion  of Fe  2§  citrate  (0.25 mg/ml),  and  sodium citrate  (1.25 
mg/ml). After 30 rain, all samples (HIV-infected  and controls) were 
treated with 95% ethanol to a final  concentration  of 70% by volume 
to inactivate the virus. The fluid was then transferred to a 4-mm 
diameter quartz glass electron paramagnetic resonance (EPK) spin 
tube and freeze-quenched in liquid nitrogen. Samples were sent 
on dry ice by express courier to the EPK facility  in the Department 
of Chemistry at Harvard University. They were kept in liquid 
nitrogen until measurement. The EPR spectra were monitored in 
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Amplification  Nucleotide 
product size  position  Primer  Sequence 
iNOS (35)  1484-1503  Sense 
614 bp  2098-2076  Antisense 
1563-1589  Probe 
B-actin (58)  3076-3096  Sense 
349 bp  3425-3405  Antisense 
HIV pol (59)  2317-2334  Sense 
282 bp  2595-2576  Antisense 
2399-2420  Probe 
GAPDH (60)  199-217  Sense 
195 bp  394-374  Antisense 
280-299  Probe 
CCAGAAGCAGAATGTGACCA 
TACATGCTGGAGCCAAGGCCAAA 
GCCAGGGGGGGCTGCCCTGCAG 
ACTGG 
GACTTAGTTGCGTTACACCC 
CCTCCCCTGTGTGGACTTGG 
GAAGCTCTATTAGATACAGG 
TCCTGGCTTTAATTTTACTGG 
GGAATTGGAGGTTTATCAAAGT 
CCATGGAGAAGGCTGGGG 
CAAAGTTGTCATGGATGACC 
CTAAGCAGTTGGTGGTGCA 
a liquid nitrogen flow-through system at a temperature of - 100~ 
on a ESP 300 E instrument  (Briiker, BiUerica, MA). 
Brain Autopsy Materials.  Cases  1-5 were HIV-1 infected, whereas 
cases 6-8 were control (uninfected). Case 1 was a 37-yr-old male 
with clinical and pathologic evidence of AIDS dementia complex; 
case 2 was a 35-yr-old male with chronic panencephalitis secondary 
to HIV-1 infection; case 3 was a 6-mo-old male with severe HIV-1 
encephalitis with numerous multinucleated giant cells and inflam- 
matory cell infiltrates in the brain; case 4 was a 12-yr-old male with 
mild HIV-1 encephalitis; case 5 was a 42-yr-old male with mild 
HIV-1 encephalitis; case 6 was a 61-yr-old female diagnosed with 
multiple sclerosis; case 7 was a 71-yr-old male with squamous cell 
carcinoma of the lung but no pathological abnormalities in his brain 
tissue; and case 8 was a 51-yr-old male with chronic active hepatitis 
who died of a hepatoceUular carcinoma and liver failure. 
Results 
HIV-1-infected Monocytes Produce NO'.  Cells were cultured 
for 7 d in the presence of M-CSF before viral infection. At 
day 6 after HIV-I~^ infection, modest but significant  levels 
of nitrites could be detected in the culture medium (Fig.  1 
A).  Peak nitrite production occurred 1 d after the peak of 
RT activity (Fig.  1 A). tLT-PCR analysis revealed induction 
of iNOS RNA by day 6 after infection, but iNOS mtLNA 
was never detected in uninfected control cultures (Fig.  1 A, 
inset). Production of nitrites by HIV-infected monocytes cor- 
related with the level of virus replication. We observed that 
significant levels of nitrites (above the background of ",~0.9 
#M) were detected when RT activity reached/>0.5  x  106 
cpm/ml. However, cells from two out of six donors did not 
produce detectable NO" even after high levels of viral repli- 
cation were established.  These cells also did not produce NO" 
after stimulation with either LPS or TNF-ot. To detect the 
presence of authentic  NO',  we used a spin-trapping  tech- 
nique that is sensitive and specific for the free radical (38). 
EPIL detection of this spin-trap complex demonstrated the 
presence of authentic NO" in culture fluids of HIV-infected 
macrophages as early as 5 d after infection (Fig.  1 B). NO" 
in culture fluids of uninfected (control) cells was undetect- 
able using this detection system. 
A recent report (25) suggested that  treatment  of mono- 
cytes with HIV-1 glycoprotein (gp)120 induces production 
of NO'.  In our system, addition of purified gpl20 at 4 or 
40 gg/ml  induced low levels of nitrites  (Fig.  2). However, 
this effect was much smaller than  the production  of NO" 
by HIV-infected cultures. Cross-linking of the macrophage 
CD4 receptor with anti-CD4 antibody or addition of equal 
(by p24)  amounts  of heat-inactivated  HIV-1  also failed to 
induce significant levels of nitrite production (data not shown). 
HIV-I Infection Can both Prime and Induce NO" Production 
by Human Monocytes.  Since LPS is known to induce NOS 
in  mouse macrophages  (40),  we tested  it  along  with  the 
proinflammatory cytokine TNF-ot for the ability to induce 
NO'-related  effects.  LPS and TNF-c~ were added to HIV- 
infected monocytes 4 d after infection when neither NO" nor 
NOS mRNA was detectable (Fig.  1 A).  As shown in Fig. 
3, A and B, both agents induced production of NO" by 24 h 
after their addition. Production of NO" was partially blocked 
by NC-methyl-t-arginine  (NMA) (Fig.  3, A  and B) and was 
completely inhibited in arginine-deficient medium (Fig. 3 A). 
In agreement with previously reported results (41),  TNF-ot 
and LPS did not significantly alter virus replication in our 
system, likely because the observation periods were of limited 
duration. Therefore, the effect of TNF-ot and LPS on iNOS 
appears not dependent on the alteration of viral replication, 
but rather on the triggering of an already primed cell. This 
effect of LPS was dose dependent, with maximal induction 
achieved  at  •10  ng/ml  (Fig.  3 B).  The  antiinflammatory 
cytokine IL-4 at 5 ng/ml diminished the effect of LPS stimu- 
lation (Fig.  3 B), demonstrating that the NO'-mediated re- 
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Figure  1.  Analysis of NOS ac- 
tivity and iNOS mRNA in cultured 
human monocytes. (A) RT activity 
and nitrite concentration were de- 
termined in culture media at daily 
intervals in HIV-infected or control 
(uninfected) monocyte cultures in 
the absence of additional  stimula- 
tion. Values obtained  for  control 
cells (0.9 #M) were subtracted from 
all corresponding  values.  Fach sample 
was  assayed in  triplicate  and the 
results are the mean _+ SD. Results 
of the RT-PCR analysis of HIV- 
infected and uninfected (control) cul- 
tures are presented in the inset. Days 
after infection are shown above the 
lanes. PCR was performed with ei- 
ther iNOS-specific primers  (PCR 
product was visualized by Southern 
hybridization  with  a  32p-labeled 
NOS-specific  probe),  or  with 
B-actin-specific  primers (PCR pro- 
duct  was  visualized by ethidium 
bromide staining). Four ~periments 
with  cells from  different  donors 
were performed and results of a rep- 
resentative experiment are shown. 
(/3) EPR illustration  of NO"  pro- 
duction by HIV-infected  monocytes 
5 d after infection. The ordinate axis 
is in arbitrary units representing the 
strength of the spin-trap signal de- 
tecting  NO',  and  the  abscissa 
represents the magnetic field strength.  A characteristic triplet  signal on 
the EPR spectrum, with a hyperfine coupling constant of 13 gauss (G), 
showed the presence of NO-Fe-DETC (39). The triplet peak was found 
at a magnetic field strength of r  G, as illustrated in the figure. After 
calibration of this number using the frequency of stimulation and cor- 
recting for solvent effects, the characteristic triplet signal was centered at 
2.039 G, as expected (39). This spectrum represents the difference  obtained 
by subtracting  signals obtained with samples of uninfected macrophages 
from HIV-infected cells. Five spectra were acquired from each sample and 
averaged before subtraction. Averaging  was performed to increase  the signal- 
to-noise  ratio, and the subtraction method was used to remove  signals  present 
in all samples due to DETC complexing with endogenous Cu  2+ . The 
resulting difference spectrum is representative of six such samples run over 
the course of macrophage infection. EPR parameters: center scan, 3318 G; 
sweep width, 220 G; microwave  frequency, 9.405 GHz; microwave  power, 
2.01 mW; modulation frequency, 100 kHz; modulation amplitude, 7.08 G; 
gain,  2.5  x  104;  time constant, 524.88 s. 
sponses  can be regulated both positively (e.g., by TNF-ce) 
and negatively (e.g., by IL-4) by the immune system. 
Whereas LPS-mediated boost of nitrite production by HIV- 
infected monocytes suggests a priming effect of HIV- 1 infec- 
tion, results presented in Fig.  1 A indicate that HIV-1 infec- 
tion per se can induce production of NO', although at later 
time points. To elucidate this question, we added LPS to mono- 
cyte cultures at various intervals after infection and measured 
NO" production by LPS-stimulated and unstimulated HIV- 
infected monocytes. For this experiment, cells were grown 
in bulk cultures in Teflon flasks. This procedure allowed us 
to avoid well-to-weU variations associated with cultures grown 
in muhi-well plates, and also produced a more rapid kinetics 
of NO" production in unstimulated cells (Table 2).  Results 
presented in Table 2  indicate that  the LPS-mediated boost 
of nitrite production can be seen only at day 5, when virus 
replication is relatively low. At later time points, stimulation 
with LPS did not  significantly affect production of NO'. 
738  HIV-infected Human Macrophages Produce Nitric Oxide Figure  2.  Nitrite  production by human monocytes  in- 
cubated  with gp120. Purified  human monocytes  were  cul- 
tured 7 d before  infection with HIV-1AD^.  For uninfected 
monocytes, cultivation was continued for an additional 
5 d, then medium was changed to a new one containing 
recombinant gp120 from HIV-lsF2  (obtained from NIH 
AIDS Research and Reference  Reagent Program, Cat. 
#386) and cells were incubated for an additional 24 h be- 
fore analysis  of nitrites. HIV-infected  cells were cultured 
for  5 d;  then the  medium was changed and  nitrite 
production was measured by the Griess reaction after 24 
h of incubation. Two experiments  with cells  from different 
donors were  performed, and results  of a representative  ex- 
periment are shown. For each time point, three separate 
wells were  prepared  and analyzed, and the presented  results 
are the mean _+ SD. 
NO" Is Produced in Co-cultures  of  HIV-infected Monocytes with 
Astroglia.  As a first  step in determining  the  role of NO" 
in HIV-induced  CNS disease,  we studied NO"  regulation 
in an experimental in vitro cell culture model.  This system 
includes  the major  cell  types  (macrophages  and  astroglia) 
thought to mediate HIV-induced neuronal injury (5, 6). 7 d 
after plating and 4 d after viral inoculation,  equal numbers 
of U251 astroglial cells were added to the virus-infected mono- 
cytes. A  significant  increase in nitrite  concentration  in  the 
culture medium occurred 48 h after the initiation of co-culture 
of the HIV-infected monocytes with astroglial cells (Fig. 4). 
Increased levels of nitrites were also detected in co-cultures 
of uninfected monocytes and astroglial  cells  (Fig.  4).  This 
latter result  suggested that  HIV infection amplified a pos- 
sibly normal set of physiological responses between mono- 
cytes and astroglia. Similarly, TNF-ot activity was detectable 
in media from co-cultures of U251 astroglial cells and unin- 
fected monocytes, but not in cultures of uninfected mono- 
cytes alone.  This  astrocyte-dependent  appearance  of bioac- 
tive TNF was further enhanced if the monocytes were infected 
with HIV-1 (Fig.  5). Since TNF-ol induces NOS in human 
astrocytes (42, 43) and HIV-infected macrophages (Fig. 3 A), 
but not in normal macrophages  (Fig.  3 A),  NOS in unin- 
fected co-cultures may well reflect an astrological cell source. 
iNOS RNA  in  the Brain  Tissue of a Pediatric Patient  with 
Severe HIV Encephalitis.  The relevance of the observed phe- 
nomena to the pathogenesis of HIV encephalitis was assessed 
by RNA PCR analysis  of brain tissue samples obtained at 
autopsy from HIV-infected subjects. Samples were obtained 
from frontal lobe and included both white and gray matter. 
Results of PCR analysis  of brain  samples with  HIV- and 
iNOS-specific primers  are  shown  in  Fig.  6.  A  product  of 
614 bp, characteristic  of iNOS was amplified from cDNA 
prepared from brain tissue of a pediatric patient with severe 
HIV encephalitis (patient 3). This patient presented the char- 
acteristic features of advanced HIV-related brain disease, with 
widespread inflammation and multinucleated giant cells. We 
did not detect iNOS RNA in samples from other patients 
with  lesser degrees  of HIV encephalitis,  or from controls 
without  microscopic evidence of neuropathology  (Fig.  6). 
Discussion 
This study demonstrates that HIV-1 infection of human 
monocytes results in the appearance of the inducible isoform 
of NOS and is accompanied by modest but significant  produc- 
tion of NO'. The effect of HIV-1 infection is likely not strain 
specific, since we observed the same phenomenon with HIV- 
lsF162 (data not shown) and HIV-1ADA strains.  This induc- 
tion of NO" synthesis occurs late during viral infection. How- 
ever, activation of HIV-infected monocytes by LPS or TNF-ot 
results in NO" production at earlier time points, before any 
NO" can be detected in HIV-infected but otherwise unstimu- 
lated cells. Later in infection, NO" production declines and 
cannot  be boosted by LPS  stimulation,  probably because 
monocytes are already fully activated for NO"  production. 
This suggests that HIV-1 can both prime and induce human 
monocytes for expression of iNOS  and  synthesis of NO'. 
NMA, a competitive inhibitor of NOS, inhibited produc- 
tion of NO" by HIV-infected human monocytes at ICs0 of 
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production by cultured monocytes.  (A) 4 d after in- 
fection with HIV-I~DA the medium was changed and 
incubation was continued for an additional 24 h in 
the presence of TNF-a (1,000 U/ml) with or without 
2 mM NMA. Uninfected monocytes were treated in 
a similar way, except  that the initial 4-d incubation 
was done without HIV. Nitrite concentration was then 
determined in the culture medium by the Griess reac- 
tion. (B) 4 d after infection with HIV-1, the medium 
was changed and incubation was continued for an ad- 
ditional 24 h in the presence of various concentrations 
of LPS and II,4 (5 ng/ml) or NMA (2 mM). Unin- 
fected monocytes were incubated with IL-4 in a similar 
way. For each experimental point, three independent 
wells with cells from the same donor were prepared. 
Results are presented as mean  _+  SD. 
740  HIV-infected Human Macrophages Produce Nitric Oxide Table  2.  Effect of LPS Stimulation  on the Nitrite Production 
by HIV-infected  Monocytes 
Days after 
infection  LPS  RT  (cpm/ml  x  106)  Nitrite  (/zM) 
5  +  0.51  _+  0.07  7.04  _+  0.02 
-  0.45  +_ 0.07  4.41  _+ 0.84 
6  +  1.32  _+  0.04  2.37  _+ 0.25 
-  1.43  +_  0.05  2.74  _+  0.24 
7  +  4.42  _+  0.21  2.79  _+  0.39 
-  4.55  _+ 0.16  2.40  _+  0.09 
Bulk cultures of monocytes (2  x  106 cells/ml) in Teflon flasks were 
either stimulated with 10 ng/ml LPS at the indicated intervals after in- 
fection or left untreated, and after 24 h, RT activity and nitrite concen- 
tration in the culture medium were assayed. Uninfected monocytes (both 
LPS stimulated and unstimulated) did not produce any detectable amount 
of nitrites in this experiment. For each time point,  three samples were 
withdrawn,  and the results are presented as mean  _+ SD. 
"~2 mM. This value is considerably higher than the ICs0 of 
20 #M reported for mouse macrophages (33, 40, 44). In this 
regard it should be noted that our experiments were performed 
in the standard DMEM medium containing 1 mM arginine, 
whereas results with murine cells were obtained with  100- 
#M concentrations of arginine.  When we lowered arginine 
concentration  to physiologically relevant  100 #M,  ICs0 for 
NMA  was ~.,100  #M  (data not  shown).  This  value is still 
five times higher than the ICs0 for murine cells under similar 
conditions.  Since NMA  competes with L-arginine for both 
the transporter and for the NOS enzyme, the observed varia- 
tion between  the murine and human cells could be attrib- 
uted  to the  differences in both  these processes. 
The NO" levels produced by human HIV-infected mono- 
cytes are significantly lower than in LPS-stimulated murine 
macrophages (19). Possibly, this species difference may be at- 
tributable to the lack of an appropriate priming and/or ac- 
tivating stimulus  for human  monocytes (26),  which  infec- 
tion with HIV-1 provides in part. In this regard, it is notable 
that recent work demonstrated that HIV primes monocytes 
for brisk immunologic responses upon subsequent activation 
(Nottet,  H.  S. L.  M.,  and H. E.  Gendelman,  unpublished 
results). LPS-activated HIV-l-infected promonocytic (45) and 
phorbol ester-activated myelomonoblastic cells (46) produce 
significantly more TNF-ot than similarly activated uninfected 
control cells. Similar results are in alveolar macrophages from 
HIV-infected patients, implying a relationship between viral 
infection and the overexpression of cytokines (47). The mech- 
anisms whereby HIV-1 primes monocytes for subsequent ac- 
tivation and iNOS induction  are not  known,  gpl20-CD4 
interaction may play some role in priming, but  HIV infec- 
tion is a much more effective stimulus than gpl20 treatment. 
Although  a  recent  report  described  high  levels of NO" 
production  by normal  human monocytes after  stimulation 
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Figure  4.  Nitrite  production  in  monocyte- 
astroglia co-culture. 4 d after infection with HIV- 
Da~A, U251 astroglial cells were added at a 1:1 
monocyte/astroglia ratio. 48 h after initiation of 
co-culture, nitrite concentration was determined 
in culture media by the Griess reaction. Uninfected 
(control) monocytes were cultured for 4 d without 
HIV-1 before initiation of coculture. Experiments 
were done with the cells  from four different  donors, 
and  results of a  representative experiment  are 
shown. For each experimental point three inde- 
pendent wells with cells from the same  donor were 
prepared and assayed, and results are presented as 
mean  _+  SD. 
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Figure  5.  Induction of TNF-c~ in monocyte- 
astroglia co-cultures.  Human monocyte cultures, 
either uninfected  or infected with HIV-I~u~A for 
4 d, were co-cultivated with U251 astroglial cells. 
At  various  times  after  initiation  of co-culture, 
TNF<x was measured in the culture medium by a 
bioassay based on the lysis  of actinomycin D-treated 
L929 cells (6). Each sample was measured in tripli- 
cate, and the results are presented as mean  _+ SD. 
with LPS  (29),  we and other groups (24,  26,  27)  did not 
observe these effects using cell culture conditions described. 
In this regard, features of monocyte cultures highly depend 
on the methods of cell isolation and propagation,  and also 
demonstrate considerable donor variability. In our study, cells 
were cultured in the presence of M-CSF for at least 7 d be- 
fore infection or stimulation, therefore were highly differen- 
tiated cells (30). We found those culture conditions optimal 
for accomplishing maximal levels of viral infection. We ob- 
served correlation between the NO" production by mono- 
cytes and the level of virus replication. Usually, levels of ni- 
trites above the background (,,o0.9/zM) were detected after 
RT activity reached 10  6 cpm/ml. However, even with high- 
level virus replication, there was a variability among donors. 
In  two  of six  experiments where RT  levels exceeded 106 
cpm/ml, NO" was not detected. Given the sensitivity of the 
Griess assay (•1  #M) and low levels of nitrite production 
Figure  6.  RT-PCR analysis of NOS RNA in brain samples. RNA ex- 
tracted from brain samples (57) was reverse transcribed  and analyzed by 
PCR with  primers  specific for HIV polymerase  (HIVmt),  iNOS,  and 
GAPDH sequences. Case numbers  are shown above the lanes. Lanes 1-5 
were from HIV-infected brains with various degrees of encephalitis,  and 
lanes 6-8 were from uninfected  brains. 
by human monocytes (,~5/~M), we cannot distinguish be- 
tween low- or nonresponding cells for NO'. 
When HIV-infected monocytes receive a triggering signal 
(which may be delivered by astroglia, TNF-ot, or LPS) early 
in infection, iNOS activity is induced through transcription 
of the iNOS gene. A similar pattern was described for mu- 
rine macrophages, where two signals  also  are required for 
induction ofiNOS, but the first (priming) signal is provided 
by IFN-y in the mouse system (44).  In human monocytes, 
IFN-'),  does not prime for iNOS transcriptional activation 
(data not  shown).  The reason for this  difference between 
murine and human macrophages is likely due to different 
signal transduction  pathways leading  to  the  activation  of 
the iNOS  gene. 
Given that relatively few productively infected brain mac- 
rophages are required to elicit progressive clinical deficits, HIV- 
induced neurotoxicity may reflect amplification of  neurotoxic 
activities by cell activation and/or interactions between in- 
fected and uninfected cells in the brain. Recent evidence has 
identified not only HIV-1 gene products, but also several host 
proinflammatory cytokines (TNF-oe,  IL-I~, PAF and eicosa- 
noids as potential neurotoxins produced by HIV-infected mac- 
rophages (5,  6).  We now demonstrate nitric oxide (NO') 
as an additional candidate virus-regulated neurotoxin. AIDS 
is associated with activation of the immune system with coin- 
cident elevated levels of TNF (8,  48,  49),  a condition that 
may promote induction ofiNOS in the infected macrophages 
of various tissues. Taking into consideration previously demon- 
strated NO'-mediated neurotoxicity associated with viral in- 
fection of the brain (21,  22,  50),  it is possible  that similar 
mechanisms operate in HIV encephalitis. The modest eleva- 
tions of NO" from HIV-infected monocytes may contribute 
to HIV-related neuronal injury similar to several other neu- 
rological diseases (21-23).  NO" may either directly (in con- 
junction with superoxide anion) damage neurons (17, 51, 52), 
or amplify production of other neurotoxins in a manner similar 
to its amplification of calcium-induced gene transcription (53). 
742  HIV-infected  Human  Macrophages  Produce  Nitric Oxide By this mechanism, the effects of low level infection of  brain 
macrophages could be amplified. Expression of iNOS is also 
a subject for negative regulation by the immune system. Our 
results demonstrate that IL-4 inhibits induction of NOS in 
LPS-stimulated HIV-infected monocytes. IL-4 was shown pre- 
viously to downregulate the priming effect of IFN-'y on pe- 
ripheral blood monocytes (54, 55). In addition, a neuroprotec- 
tive role of IL-4 against activated microglia was recently 
described (56).  Taken together, these data suggest a protec- 
tive role for IL-4 in HIV-induced brain disease. 
We were able to detect expression of iNOS in the brain 
tissue of a pediatric patient with severe, late-stage HIV en- 
cephalitis, indicating that iNOS can be induced during HIV- 
induced brain disease. The events that lead to the ADC are 
not yet fully understood, but probably reflect the interplay 
between the neurotoxic (e.g., PAF, arachidonic acid metabo- 
lites, NO') and neuroprotective (e.g., IL-4, TGF-/3) factors 
produced in the brain by macrophages and astroglial cells. 
Failure of the neuroprotective mechanisms is, most likely, the 
cause of uncontrolled activation associated with the develop- 
ment of cognitive and motor dysfunctions. The role of NO" 
in these events is still unclear, since we did not observe a strong 
correlation between iNOS expression in the brain and AIDS 
dementia. It is likely that NO" is only one of many factors 
leading to disease progression. Elucidation of the pathogenic 
role of NO" in ADC, for instance,  through experiments ex- 
ploiting animal models of AIDS, may suggest new avenues 
for therapeutic intervention against the neurological compli- 
cations of HIV infection. 
We thank C. Cheng-Mayer  for HIV-lsF16r-infected  macrophages; N. Oyaizu and S. Pahwa for CD4 cross- 
linking experiments; B. Sherry  for helpful suggestions; K. Manogue and K. Warren for critical reading 
of the manuscript; and K. Spiegel for outstanding administrative support. 
This work was supported by grants 02059-15-RGR (M. I. Bukrinsky) and 02065-15-RGR (H. E. Gen- 
delman) from the American  Foundation  for AIDS Research; by NIH grants POINS31492-01, POIHL43628- 
05 (H. E. Gendelman) and PO1HD29587-02 (S. A. Lipton); and by the University of Nebraska Biotech- 
nology start up funds (H. E. Gendelman). H. E. Gendelman is a Carter Wallace  Fellow in the Department 
of Pathology and Microbiology; H. S. L. M. Nottet is a Nicholas B. Badami Scholar in the Laboratory 
of Viral Pathogenesis; M. E. Mullins is the recipient of a Medical Scientist Training Program scholarship 
in the M.D.-Ph.D.  Program at Harvard Medical School. 
Address correspondence to Dr. M. Bukrinsky, The Picower Institute for Medical Research, 350 Commu- 
nity Drive, Manhasset, NY 11030. 
Received for publication 11 July 1994 and in revised form 6  October 1994. 
l~es 
1.  Navia, B.A., B.D. Jordan, and tL.W. Price. 1986. The AIDS 
dementia  complex. I. Clinical  features.  Ann. Neurol. 19:517-524. 
2.  Price, R.W., J. Sidtis, and M. Rosenblum. 1988. The AIDS 
dementia  complex:  some current  questions. Ann.  Neurol. 
23:$27-$33. 
3.  Koenig, S., H.E. Gendelman,  J.M. Orenstein, M.C. DalCanto, 
G.H.K. Pezeshikpour, I.M. Yungbluth, F. Jannotta,  A. Ak- 
samit, M.A. Martin, and A.S. Fauci. 1986. Detection of AIDS 
virus in macrophages in brain tissue from AIDS patients with 
encephalopathy. Science (Wash. DC). 233:1089-1093. 
4.  Wiley, C.A., R.D. Schrier, J.A. Nelson, P.W. Lampert, and 
M.B.A. Oldstone. 1986. Cellular localization of human im- 
munodeficiency  virus infection within the brains of acquired 
immune deficiency syndrome patients. Pro~ Natl. Acad. Sci. 
USA.  83:7089-7093. 
5.  Gelbard, H.A., H.S.L.M. Nottet, S. Swindells,  M. Jett, K.A. 
Dzenko, P. Genis, R. White, L. Wang, Y.-B. Choi, D. Zhang, 
et al. 1994. Platelet-activating factor: a candidate human im- 
munodeficiency  virus type 1-induced neurotoxin.J.  Virol. 68: 
4628-4635. 
6.  Genis, P., M. Jett, E.W. Bemton, T. Boyle, H.A. Gelbard, 
K. Dzenko, R.W. Keane,  L. Resnick, Y. Mizrachi, D.J. Volsky, 
et al. 1992. Cytokines and arachidonic metabolites produced 
743  Bukrinsky  et al. 
during human immunodeficiency  virus (HIV)-infected mac- 
rophage-astroglia  interactions:  implications  for the neuropatho- 
genesis of HIV disease.  J. Exlx Med. 176:1703-1718. 
7.  Griffin, D.E., J.C. McArthur, and D.K. Comblath. 1991. Ne- 
opterin and interferon-gamma  in serum and cerebrospinal  fluid 
in patients with HIV-1 associated  neurologic  disease. Neurology. 
41:69-74. 
8.  Grimaldi, L.M.E., G.V. Martino, D.M. Franciotta, R. Brustia, 
A. Castagna, IL. Pristera, and A. Lazzarin. 1991. Elevated  alpha- 
tumor necrosis factor levels  in spinal fluid from HIV-l-infected 
patients with central nervous system  involvement.  Ann. Neurol. 
29:21-25. 
9.  Giulian, D., K. Vaca, and C.A. Noonan.  1990. Secretion of 
neurotoxins by mononuclear phagocytes infected with HIV-1. 
Science (Wash. DC). 250:1593-1596. 
10.  Lipton, S.A. 1992. Models of neuronal injury in AIDS: an- 
other role for the NMDA receptor? Trends  Neurosci. 15:75-79. 
11.  Lipton, S.A., P.K. Kaiser, N.J. Sucher, E.B. Dreyer, and J.T. 
Offermann. 1990. AIDS virus coat protein sensitizes  neurons 
to NMDA  receptor-mediated toxicity. Soc  Neurosci. Abstr. 
16:289. 
12. Lipton, S.A., N.J. Sucher, and E.B. Dreyer. 1991. Synergistic 
effects of HIV coat protein and NMDA receptor-mediated  neu- rotoxicity. Neuron. 7:111-118. 
13.  Savio, T., and G. Levi. 1993. Neurotoxicity of HIV coat pro- 
tein gp120 NMDA receptors, and protein kinase C: a study 
with  rat  cerebellar granule  cell cultures. J.  Neurosci. Res. 
34:265-272. 
14.  Dawson,  V.L., T.M. Dawson,  G.R. Uhl, and S.H. Snyder. 
1993. HIV-1 coat protein  neurotoxicity mediated by nitric 
oxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 
90:3256-3259. 
15.  Dreyer, E.B., K. Kaiser,  J.T. Offerman, and S.A. Lipton. 1990. 
HIV-1 coat protein neurotoxicity prevented by calcium channel 
antagonists. Science (Wash. DC). 248:364-367. 
16.  Dawson, V.L., T.M. Dawson, E.D. London, D.S. Bredt, and 
S.H. Snyder. 1991. Nitric oxide mediates glutamate neurotox- 
icity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 
88:6368-6371. 
17.  Lipton, S.A., Y.-B. Choi, Z.-H. Pan, S.Z. Lei, H.-S.V. Chen, 
N.J.  Sucher, J. Loscalzo, D.J. Singe1, and J.S. Stamler. 1993. 
A redox-based mechanism for the neuroprotective and neu- 
rodestructive  effects of nitric  oxide  and  related  nitroso- 
compounds. Nature (Lond.). 364:626-632. 
18.  Karupiah, G., Q.W. Xie, R.M. Buller, C. Nathan, C. Duarte, 
and J.D. MacMicking. 1993. Inhibition of viral replication by 
interferon-gamma-induced nitric oxide synthase. Science  (Wash. 
DC). 261:1445-1448. 
19.  Nathan, C. 1992. Nitric oxide as a secretory product of mam- 
malian cells. FASEB (Fed. Am. Soc. Exp. Biol.).J. 6:3051-3064. 
20.  Moncada, S., R.M.J.  Palmer, and E.A.  Higgs.  1991. Nitric 
oxide physiology, pathophysiology, and pharmacology. Phar- 
macol. Rev. 43:109-142. 
21.  Dawson, V.L., T.M. Dawson, D.A.  Bartley, G.R. Uhl, and 
S.H. Snyder. 1993. Mechanisms of nitric oxide-mediated neu- 
rotoxicity in primary brain cultures.J. Neurosci. 13:2651-2661. 
22.  Zheng, Y.M., M.K. Schafer,  E. Weihe, H. Sheng, S. Corisdeo, 
Z.F. Fu, H. Koprowski, and B. Dietzschold.  1993. Severity 
of neurological signs and degree of inflammatory lesions in 
the brains of rats with Borna disease correlate with the induc- 
tion of nitric oxide synthase. J.  Virol. 67:5786-5791. 
23.  Koprowski, H., Y.M. Zheng, E. Heber-Katz,  N. Fraser, L. 
Rorke, Z.F. Fu, C. Hanlon, and B. Dietzschold. 1993. In vivo 
expression of  inducible nitric oxide synthase in experimentally 
induced neurologic diseases. Proa Natl. Acad. Sci. USA.  90: 
3024-3027. 
24.  Schneeman, M., G. Schoedon, S. Hofer, N. Blau, L. Guer- 
rero, and A. Schaffner. 1993. Nitric oxide synthase is not a 
constituent of the antimicrobial armature of human mononu- 
clear phagocytes. J.  Infect. Dis. 167:1358-1363. 
25.  Pietraforte, D., E. Tritarelli, U. Testa, and M. Minetti.  1994. 
gp120 HIV envelope glycoprotein increases the production of 
nitric oxide human monocyte-derived macrophages.  J. Leuko- 
cyte Biol. 55:175-182. 
26.  Padgett,  E.L., and S.B. Pruett.  1992. Evaluation of nitrite 
production by human monocyte-derived  macrophages. Biochem. 
Biophys. Res.  Commun.  186:775-781. 
27.  Sakai, N., and S. Milstein. 1993. Availability of tetrahydrobi- 
opterin  is not a factor in the inability to detect nitric oxide 
production by human  macrophages. Biochem. Biophys. Res. 
Commun.  193:378-383. 
28.  Zembala,  M., M. Siedlar,  J. Marcinkiewicz, andJ. Pryjma. 1994. 
Human monocytes are stimulated for nitric oxide release in 
vitro by some tumor cells but not by cytokines and lipopoly- 
saccharide. Eur. J. Immunol.  24:435-439. 
29.  Leibovich, S.J., P.J. Polverini, T.W. Fong, L.A. Halow, and 
A.E. Koch. 1994. Production  of angiogenic activity by hu- 
man monocytes requires an L-arginine/nitric oxide-synthase- 
dependent effector mechanism. Proc. Natl. Acad. Sci. USA. 91: 
4190-4194. 
30.  Rich, E.A., I.S. Chen, J.A. Zack, M.L. Leonard, and W.A. 
O'Brien.  1992. Increased  susceptibility  of  differentiated 
mononuclear phagocyte to productive infection with human 
immunodeficiency virus-1 (HIV-1).J. Clin. Invest. 89:176-183. 
31.  Rich,  E.A.,  J.R.  Panuska, R.S.  Wallis, C.B. Wolf,  M.L. 
Leonard, and J.J.  Ellner. 1989. Dyscoordinate expression of 
tumor necrosis factor-alpha by human blood monocytes and 
alveolar macrophages. Am. Rev. Respir. Dis. 139:1010-1016. 
32.  Bigner, D.D., S.H. Bigner, J. Ponten, B. Westermark, M.S. 
Mahaley, E. Ruoshht, H. Herschman, L.F. Engl, and C.J. Wik- 
strand. 1981. Heterogeneity of  genotypic and phenotypic char- 
acteristics of fifteen permanent cell lines derived from human 
gliomas. J. Neuropathol. Exp.  Neurol. 40:201-212. 
33.  Xie,  Q.W., H.J.  Cho, J.  Calaycay, R.A.  Mumford,  K.M. 
Swiderek, T.D. Lee, A. Ding, T. Troso, and C. Nathan.  1992. 
Cloning and characterization of  inducible nitric oxide synthase 
from mouse macrophages. Science (Wash. DC). 256:225-228. 
34. Janssens, S.P., A. Shimouchi, T. Quertermous,  D.B. Bloch, 
and K.D. Bloch. 1992. Cloning  and expression of a cDNA 
encoding human  endothelium-derived relaxing factor/nitric 
oxide synthase. J. Biol. Chem.  267:14519-14522. 
35.  Geller, D.A.,  C.J. Lowenstein, R.A. Shapiro, A.K. Nussler, 
M. Di Silvio, S.C. Wang, D.K.  Nakayama, R.L. Simmons, 
S.H. Snyder, and T.R. Billiar. 1993. Molecular cloning and 
expression of inducible nitric oxide synthase from human he- 
patocytes. Proc. Natl.  Acad. Sci. USA.  90:3491-3495. 
36.  Green, L.C., D.A. Wagner, J. Glogowski, P.L. Skipper, J.S. 
Wishnok, and S.R. Tannenbaum. 1982. Analysis of nitrate, 
nitrite and  [lSN]nitrate in biological fluids. Anal.  Biochem. 
126:131-138. 
37.  Henry, Y.,  M.  Lepoivre, J.-C.  Drapier,  C.  Ducrocq, J.-L. 
Boucher, and A. Guissani. 1993. EPK characterization of mo- 
lecular targets  for NO in  mammalian cells and organelles. 
FASEB (Fed. Am. Soc. Exp. Biol.) J.  7:1124-1134. 
38.  Mordvintcev, P., A. Mulsch, K. Busse, and A. Vanin. 1991. 
On-line detection of nitric oxide formation in liquid aqueous 
phase by electron paramagnetic resonance spectroscopy.  Anal. 
Biochem. 199:142-146. 
39.  Tominaga, T., S. Sato, T. Ohnishi,  and S.T. Ohnishi.  1993. 
Potentiation of nitric oxide formation following  bilateral carotid 
occlusion and focal cerebral ischemia in the rat: in vivo detec- 
tion of the nitric oxide radical by electron paramagnetic reso- 
nance spin trapping. Brain Res. 614:342-346. 
40.  Stuehr, D.J.,  H.J.  Cho,  N.S. Kwon,  M.F. Weise, and C.F. 
Nathan.  1991. Purification and characterization of the cyto- 
kine-induced macrophage nitric oxide synthase: an FAD- and 
FMN-containing flavoprotein. Proc. Natl. Acad. Sci. USA. 88: 
7773-7777. 
41.  Bernstein, M.S., S.E. Tong-Starksen,  and K.M. Locksley.  1991. 
Activation of human monocyte-derived macrophages with li- 
popolysaccharide decreases human  immunodeficiency virus 
replication in vitro at the level of gene expression.  J. Clin. In- 
vest. 88:540-545. 
42.  Lee, S.C., D.W. Dickson,  W. Liu, and C.F. Brosnan. 1993. 
Induction of nitric oxide synthase activity in human astrocytes 
by interleukin-1 beta and interferon-gamma.J. Neuroimmunol. 
46:19-24. 
43.  Mollace,  V., M. Colasanti, P. Rodino, K. Massoud, G.M. Lauro, 
and G. Nistico. 1993. Cytokine-induced nitric oxide genera- 
744  HIV-infected  Human Macrophages Produce Nitric Oxide tion by cultured astrocytoma cells involves Ca(+ +)-calmodulin- 
independent NO-synthase. Biochern. Biophys. Res. Commun. 
191:327-334. 
44.  Ding, A.H., C.F. Nathan, and D.J.  Stuehr.  1988. Release of 
reactive  nitrogen  intermediates  and  reactive  oxygen inter- 
mediates  from mouse peritoneal macrophages. J.  Immunol. 
141:2407-2412. 
45.  D'Addario, M., A. Roulston, M.A. Wainberg, andJ. Hiscott. 
1990.  Coordinate enhancement of cytokine gene expression 
in human immunodeficiency virus type-l-infected promono- 
cytic cells. J.  Virol. 64:6080-6089. 
46.  D'Addario,  M., M.A. Wainberg, andJ. Hiscott. 1992. Activa- 
tion of cytokine genes in HIV-1 infected myelomonoblastic cells 
by phorbol ester and tumor necrosis factor. J. Immunol. 148: 
1222-1229. 
47.  Buhl, R., H.A. Jaffe, K.J. Holroyd, Z. Borok, J.H. Roum, 
A. Mastrangeli, F.B. Wells,  M.  Kirby, C. Saltini,  and R.G. 
Crystal. 1993. Activation of alveolar macrophages in asymp- 
tomatic HIV-infected individuals. J. Immunol. 150:1019-1028. 
48.  von Sydow, R.S., A. Sonnerborg, H. Gaines, and O. Stran- 
negard. 1991. Interferon-alpha and tumor necrosis factor-alpha 
in serum of patients in various stages of HIV-1 infection. AIDS 
Res. Hum.  Retroviruses. 7:375-380. 
49.  Arditi,  M.,  W.  Kabat,  and R.  Yogev. 1991. Serum tumor 
necrosis factor alpha, interleukin 1-beta, p24 antigen concen- 
trations  and  CD4 +  cells  at  various  stages  of human  im- 
munodeficiency virus 1 infection in children. Pediatr. Infect. Eh's. 
J.  10:450-455. 
50.  Choi, D.W.  1993. Nitric oxide:  foe or friend to the injured 
brain? Proc. Natl.  A_cad. Sci. USA.  90:9741-9743. 
51.  Meldrum, B., andJ. Garthwaite. 1990. Excitatory amino acid 
neurotoxicity and neurodegenerative disease. Trends  Pharmacol. 
Sci. 11:379-387. 
52.  Choi, D.W. 1988. Glutamate neurotoxicity and diseases of the 
nervous system.  Neuron. 1:623-634. 
53.  Peunova,  N.,  and  G.  Enikolopov.  1993.  Amplification  of 
calcium-induced  gene transcription by nitric oxide in neuronal 
cells. Nature (Lond.). 364:450-453. 
54.  Lehn, M.,  W.Y. Weiser,  S.  Engelhorn,  S.  Gillis,  and H.G. 
Remold. 1989. IL-4 inhibits H202 production and antileish- 
manial capacity of human cultured monocytes mediated by 
IFN-  7. J. Immunol. 143:3020-3027. 
55.  Figdor, C.G., and A.A. te Velde. 1992. Regulation of human 
monocyte phenotype and function by interleukin-4. In IL-4: 
Structure and Function. H. Spits, editor. CRC  Press, Boca 
Raton, FL.  187-203. 
56.  Chao, C.C., T.W. Molitor, and S. Hu. 1993. Neuroprotective 
role  of IL-4 against  activated  microglia. J.  Immunol. 151: 
1473-1481. 
57.  Chomczynski, P., and N. Sacchi.  1987. Single-step  method 
of R.NA  isolation  by  acid  quanidium  thiocyanate-phenol- 
chloroform extraction. Anal.  Biochem. 162:156-159. 
58.  Hanukoglu, I., N. Tanese, and E. Fuchs. 1983. Complementary 
DNA sequence of a human cytoplasmic actin. Interspecies diver- 
gence of 3' non-coding regions. J. Mol. Biol. 163:373-678. 
59.  Rather, L., W. Haseltine, R. Patarca, K.J. Livak, B. Starcich, 
S. Josephs, E. Doran, A.  Rafalski,  E. Whitehorn,  K. Bau- 
meister, et al. 1985. Complete nucleotide sequence of the AIDS 
virus,  HTLV-III. Nature (Lond.). 313:277-283. 
60.  Hanauer, A., andJ.L. Mandel. 1984. The glyceraldehyde 3 phos- 
phate dehydrogenase gene family: structure of a human cDNA 
and of an X chromosome linked pseudogene; amazing com- 
plexity of the gene family in mouse. EMBO (Eur. Mol. Biol. 
Organ.) J. 3:2627-2633. 
745  Bukrinsky  et al. 